The US Food and Drug Administration (FDA) has approved the first artificial iris for use in adults and children with congenital aniridia or iris defects due to other reasons or conditions, such as ...

The "Artificial Iris Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artificial Iris Market has shown significant growth, expanding from USD 17.71 million ...

The field of artificial iris implantation has seen notable advancements aimed at restoring both ocular function and cosmetic appearance in individuals affected by congenital or acquired iris defects.

Clinical Research Consultants’ CustomFlex Artificial Iris is a surgically implanted device for patients whose iris is missing or damaged. The artificial iris is comprised of a thin, foldable silicone ...

The FDA has signed off on many innovative medical devices, software platforms and drug therapies this year that aim to improve patient care. 1. A combination of Bristol-Myers Squibb’s cancer drugs ...